Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Surgery

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e31828920c0PMID 23532112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

  2012cited by this paper
• Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer

  2012cited by this paper
• Prognostic significance of the extent of visceral pleural invasion in completely resected node-negative non-small cell lung cancer.

  2012cited by this paper
• Stage I non-small cell lung cancer: the presence of the lymphocyte-specific protein tyrosin kinase in the tumour infiltrate is associated with a better long-term prognosis.

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

  2011cited by this paper
• Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

  2011cited by this paper
• Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

  2011cited by this paper
• Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis

  2010cited by this paper
• Time Trends of Surgical Outcome in Patients with Non-small Cell Lung Cancer

  2010cited by this paper
• Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm

  2010cited by this paper
• F1000 highlights

  2010cited by this paper
• A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

  2010cited by this paper
• Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

  2010cited by this paper
• Limited Resection for the Treatment of Patients With Stage IA Lung Cancer

  2010cited by this paper
• Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

  2010cited by this paper
• Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.

  2009cited by this paper
• F1000 highlights

  2009cited by this paper
• Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

  2009cited by this paper
• Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer

  2008cited by this paper
• The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

  2008cited by this paper
• Postrecurrence survival in patients with stage I non-small cell lung cancer.

  2008cited by this paper
• Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

  2008cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.

  2007cited by this paper
• Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.

  2007cited by this paper
• Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

  2006cited by this paper
• International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising

  2005cited by this paper
• Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.

  2005cited by this paper
• Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis

  2005cited by this paper
• Pathology & Genetics Tumours of the lung, Pleura, Thymus and Heart

  2004cited by this paper
• Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

  2004cited by this paper
• Prognostic value of visceral pleura invasion in non-small cell lung cancer.

  2003cited by this paper
• Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.

  2001cited by this paper
• Stage I nonsmall cell lung cancer : a multivariate analysis of treatment methods and patterns of recurrence

  1995cited by this paper
• Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

  1995cited by this paper
• Incidence of local recurrence and second primary tumors in resected stage I lung cancer.

  1995cited by this paper
• Multiple primary lung cancers.

  1975cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Development of a comprehensive model combining clinical, radiomics with deep learning for predicting the micropapillary pattern in ≤ 2cm invasive lung adenocarcinoma.

  2026cites this paper
• A pulmonary nodule is worth 8 × 8 × 8 words: computed tomography-based 3D vision transformer predicts early-stage high-grade lung adenocarcinoma of micropapillary and/or solid subtypes

  2025cites this paper
• Density and Maturity of Tertiary Lymphoid Structures Predict Clinical Outcome in Invasive Lung Adenocarcinoma

  2025cites this paper
• High-grade histological patterns in metastatic lymph nodes associated with poor prognosis in resected lung adenocarcinoma: a multicentre retrospective cohort study.

  2025cites this paper
• Integrative prognostic model incorporating high mobility group box 1 subcellular localization and tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma

  2025cites this paper
• Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies

  2025cites this paper
• Tobacco smoking is associated with solid growth pattern in primary lung adenocarcinoma

  2025cites this paper
• Oncologic Outcomes of Thoracoscopic Segmentectomy in Patients with High-Grade Adenocarcinoma Pattern

  2025cites this paper
• Quantifying intratumoral heterogeneity within sub-regions to predict high-grade patterns in clinical stage I solid lung adenocarcinoma

  2025cites this paper
• The Critical Role of Minor Histological Patterns in Prognosis Prediction in Early-Stage Lung Adenocarcinomas

  2025cites this paper
• LungPath: artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinoma

  2024cites this paper
• Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern

  2024cites this paper
• Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma

  2024cites this paper
• The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes

  2024cites this paper
• Multimodal deep learning radiomics model for predicting postoperative progression in solid stage I non-small cell lung cancer

  2024influential citation
• Precise diagnosis and prognosis assessment of malignant lung nodules: a narrative review

  2024cites this paper
• High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma

  2024cites this paper
• Deep Learning Model for Pathological Grading and Prognostic Assessment of Lung Cancer Using CT Imaging: A Study on NLST and External Validation Cohorts.

  2024cites this paper
• Predicting High-Grade Patterns in Stage I Solid Lung Adenocarcinoma: A Study of 371 Patients Using Refined Radiomics and Deep Learning-Guided CatBoost Classifier

  2024cites this paper
• Predicting occult lymph node metastasis in solid-predominantly invasive lung adenocarcinoma across multiple centers using radiomics-deep learning fusion model

  2024cites this paper
• Dual-energy CT-based radiomics for predicting pathological grading of invasive lung adenocarcinoma.

  2024cites this paper
• A Multi-institutional Analysis of the Combined Effect of Micropapillary Component and Consolidation-to-Tumor Ratio >0.5 on the Prognosis of Pathological, Stage IA3, Lung Adenocarcinoma

  2023cites this paper
• Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes

  2023cites this paper
• Establishment and visualization of a model based on high-resolution CT qualitative and quantitative features for prediction of micropapillary or solid components in invasive lung adenocarcinoma

  2023cites this paper
• Prediction of high-grade patterns of stage IA lung invasive adenocarcinoma based on high-resolution CT features: a bicentric study

  2023cites this paper
• Factors influencing postoperative recurrence of early-stage non-small cell lung cancer

  2023cites this paper
• Development of a predictive model to predict postoperative bone metastasis in pathological I–II non-small cell lung cancer

  2023cites this paper
• Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.

  2023cites this paper
• Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma

  2023cites this paper
• Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights.

  2023cites this paper
• Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management.

  2023cites this paper
• Metastatic spread of primary lung adenocarcinoma to the small intestine: A case report

  2023cites this paper
• Prognostic significance of limited resection in pathologic stage I lung adenocarcinoma with spread through air spaces

  2023cites this paper
• Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study

  2022cites this paper
• Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.

  2022cites this paper
• Establishment and validation of a radiological-radiomics model for predicting high-grade patterns of lung adenocarcinoma less than or equal to 3 cm

  2022cites this paper
• Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component

  2022cites this paper
• Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography

  2022cites this paper
• Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment.

  2022cites this paper
• Prognostic Implications of the Predominant Histologic Subtype in Stage I Lung Adenocarcinoma: Lack of Association with Overall Survival Based on Multi-Aspect Survival Analyses

  2022cites this paper
• Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes

  2022cites this paper
• A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer

  2022cites this paper
• Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification

  2022cites this paper
• Immunogenomic profiling of lung adenocarcinoma reveals high-grade growth patterns are associated with an immunogenic tumor microenvironment

  2022cites this paper
• A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics

  2021cites this paper
• The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role

  2021cites this paper
• The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma

  2021cites this paper
• Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma

  2021cites this paper
• Invasive adenocarcinoma manifesting as pure ground glass nodule with different size: radiological characteristics differ while prognosis remains the same

  2021cites this paper
• Subsolid lung adenocarcinomas: Radiological, clinical and pathological features and outcomes.

  2021cites this paper
• Genomic profiling reveals non-small cell lung cancer with common mutations of EGFR exon 20 and exon 21: a case report

  2021cites this paper
• Clinicopathological predictors of survival in resected primary lung adenocarcinoma

  2021cites this paper
• Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinoma.

  2021cites this paper
• High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.

  2021cites this paper
• Opere Erken Evre Akciğer Kanseri Hastalarında Prognostik Faktörler Retrospektif Tek Merkez Sonuçları

  2020cites this paper
• Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.

  2020cites this paper
• Malignant Epithelial Tumors of the Lung

  2020cites this paper
• New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma

  2020cites this paper
• Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database

  2020cites this paper
• 肺微乳头腺癌病理学及分子学特征研究进展

  2020cites this paper
• 2D and 3D texture analysis to predict lymphovascular invasion in lung adenocarcinoma.

  2020cites this paper
• Deep learning combined with radiomics may optimize the prediction in differentiating high-grade lung adenocarcinomas in ground glass opacity lesions on CT scans.

  2020cites this paper
• Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma

  2020cites this paper
• Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease.

  2020cites this paper
• Procedure-specific prognostic impact of micropapillary subtype may guide resection strategy in small-sized lung adenocarcinomas: a multicenter study

  2020cites this paper
• A signature related to lung adenocarcinoma prognosis: A study based on TCGA database

  2020cites this paper
• A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients

  2020cites this paper
• TERT Mutation was Associated with the Risk of Recurrence in Lung Adenocarcinoma with A Micropapillary Pattern

  2020cites this paper
• Correlation between CXCR5 expression and prognosis in stage T1 non-small cell lung cancer

  2020cites this paper
• The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.

  2020cites this paper
• Long noncoding RNA HOXC-AS3 facilitates the progression of invasive mucinous adenocarcinomas of the lung via modulating FUS/FOXM1

  2020cites this paper
• Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component.

  2020cites this paper
• Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery.

  2020cites this paper
• Comprehensive circular RNA profiling identifies CircFAM120A as a new biomarker of hypoxic lung adenocarcinoma.

  2019cites this paper
• Occult mediastinal lymph node metastasis in FDG‐PET/CT node‐negative lung adenocarcinoma patients: Risk factors and histopathological study

  2019cites this paper
• Problems in the reproducibility of classification of small lung adenocarcinoma: an international interobserver study

  2019cites this paper
• Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologists.

  2019cites this paper
• Prognostic Impact of Tumor Spread Through Air Spaces in Sublobar Resection for 1A Lung Adenocarcinoma Patients

  2019cites this paper
• Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer

  2019cites this paper
• Utility of core biopsy to identify histologic subtype and predict outcome for lung adenocarcinoma.

  2019cites this paper
• Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma.

  2019cites this paper
• Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations

  2019cites this paper
• Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy

  2019cites this paper
• Analysis of Histological Grade in Resected Lung-invasive Adenocarcinoma

  2019cites this paper
• Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy

  2019cites this paper
• Distinct prognostic factors in patients with stage I non-small cell lung cancer with radiologic part solid or solid lesions.

  2019cites this paper
• Cribriform pattern in lung invasive adenocarcinoma correlates with poor prognosis in a Chinese cohort.

  2019cites this paper
• Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe

  2019cites this paper
• Intensity of SLX predicts distance of tumor spread through alveolar spaces in stage I lung adenocarcinoma

  2019cites this paper
• Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma

  2019cites this paper
• TMEM213 as a novel prognostic and predictive biomarker for patients with lung adenocarcinoma after curative resection: a study based on bioinformatics analysis.

  2019cites this paper
• Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.

  2019cites this paper
• Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non–small cell lung cancer

  2018cites this paper
• Podoplanin expression in cancer‐associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma

  2018cites this paper
• Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist.

  2018cites this paper
• Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma

  2018cites this paper
• Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma.

  2018cites this paper
• Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection

  2018cites this paper
• Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma

  2018cites this paper
• A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component

  2018cites this paper